Quick Answer
Silexion Therapeutics Corp reported Earnings Per Share Diluted of $8.96 per share for the year ending 2025.
- Silexion Therapeutics Corp showed a decrease of -97.7% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Silexion Therapeutics Corp's annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $6.54 per share | Q3 2023: $0.78 per share | Q1 2024: $12.29 per share | Q2 2024: $197.80 per share | Q3 2024: $274.25 per share | Q1 2025: $0.26 per share | Q2 2025: $4.32 per share | Q3 2025: $2.88 per share.
- Over the full 3 years of available data (2023 to 2025), Silexion Therapeutics Corp's Earnings Per Share Diluted has declined by 79.7%.
- Historical annual values: Fiscal year 2025: $8.96 per share | Fiscal year 2024: $394.94 per share | Fiscal year 2023: $44.23 per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: